First, the expression of β-catenin and TCF4 was analyzed in freshly resected aggressive HBL samples (n = 5), including three samples lacking deletion/mutation in exon 3 of β-catenin (Supplementary Figure S1). This evidence concerns the gene TCF4 and hepatoblastoma.